SKI Market

A+| A| A-|

Indian Indices

Sensex

78,493.54 504.86
( 0.65%)

Global Indices

Nasdaq

49,467.44 867.71
(1.79%)

Dow Jones

7,146.92 84.64
(1.20%)

Hang Seng

58,837.37 -680.97
(-1.14%)

Nikkei 225

10,660.47 70.48
(0.67%)

Forex

USD-INR

93.19 -0.12
(-0.13%)

EUR-INR

109.85 -0.18
(-0.16%)

GBP-INR

126.25 -0.31
(-0.25%)

JPY-INR

0.59 0.00
(-0.15%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Mankind Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

543904

INE634S01028

375.7133845

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

MANKIND

49.61

87651.71

EPS(TTM)

Face Value()

Div & Yield %

42.8

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	9497.80	8629.25	8127.15	7486.22	5529.60	4794.41
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	9497.80	8629.25	8127.15	7486.22	5529.60	4794.41
Other Income	554.44	374.03	162.78	203.81	148.08	93.85
Stock Adjustments	13.50	48.20	-267.89	365.27	254.25	44.51
Total Income	10065.74	9051.48	8022.04	8055.30	5931.93	4932.77
EXPENDITURE :
Raw Materials	2610.39	2618.31	2576.87	2886.71	2036.42	1617.42
Power & Fuel Cost	88.97	80.91	62.00	60.36	47.16	46.49
Employee Cost	2131.67	1921.09	1701.38	1462.76	1106.14	991.47
Other Manufacturing Expenses	203.70	145.78	113.62	93.57	56.71	57.73
Selling & Administrative Expenses	1770.41	1518.78	1539.07	1378.52	966.82	696.80
Miscellaneous Expenses	143.09	125.69	168.47	131.08	192.07	185.06
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	6948.23	6410.56	6161.40	6013.00	4405.31	3594.98
Operating Profit	3117.51	2640.92	1860.65	2042.30	1526.62	1337.79
Interest	372.28	16.93	28.23	47.54	8.23	11.10
Gross Profit	2745.23	2623.99	1832.42	1994.76	1518.39	1326.69
Depreciation	378.01	335.26	269.58	123.33	78.19	61.77
Profit Before Tax	2367.22	2288.73	1562.84	1871.43	1440.20	1264.92
Tax	469.93	411.33	291.64	429.03	346.99	341.81
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-48.19	1.24	22.94	52.98	8.84	-35.11
Reported Net Profit	1945.48	1876.16	1248.26	1389.42	1084.37	958.23
Extraordinary Items	254.30	105.89	29.02	62.07	30.15	18.58
Adjusted Net Profit	1691.18	1770.27	1219.24	1327.35	1054.22	939.65
Adjustment below Net Profit	4.98	-6.66	-4.86	-0.79	-1.56	-69.15
P & L Balance brought forward	9763.97	7894.47	6624.90	5236.27	3747.13	3160.50
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	0.00	0.00	302.44
P & L Balance carried down	11714.43	9763.97	7868.30	6624.90	4829.95	3747.13
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	755.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	7.55
Earnings Per Share-Unit Curr	47.15	46.83	31.16	34.68	27.07	23.92
Earnings Per Share(Adj)-Unit Curr	47.15	46.83	31.16	34.68	27.07	23.92
Book Value-Unit Curr	354.83	242.21	194.31	163.27	118.18	91.15
Book Value(Adj)-Unit Curr	354.83	242.21	194.31	163.27	118.18	91.15

78,493.54 504.86 ( 0.65%)

49,467.44 867.71 (1.79%)

7,146.92 84.64 (1.20%)

58,837.37 -680.97 (-1.14%)

10,660.47 70.48 (0.67%)

93.19 -0.12 (-0.13%)

109.85 -0.18 (-0.16%)

126.25 -0.31 (-0.25%)

0.59 0.00 (-0.15%)